Patents by Inventor Chrystal U. Louis

Chrystal U. Louis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180169230
    Abstract: The disclosure provides methods of treatment for cancer in patients using bispecific anti-IGF-1R, anti-ErbB3 antibodies in combination with one or more therapeutic agents that impede regulatory T-cell agents. In certain embodiments, said one or more therapeutic agent may be an antagonistic anti-receptor antibody that immunospecifically binds human PD-L1.
    Type: Application
    Filed: May 27, 2016
    Publication date: June 21, 2018
    Inventors: Sharlene ADAMS, Michael CURLEY, Gregory J. FINN, Chrystal U. LOUIS, Alexey Alexandrovich LUGOVSKOY
  • Publication number: 20170233491
    Abstract: Disclosed herein are methods of treating pancreatic cancer in a human patient by co-administering istiratumab in combination with gemcitabine and nab-paclitaxel, and dosage regimens for the same.
    Type: Application
    Filed: January 19, 2017
    Publication date: August 17, 2017
    Applicant: Merrimack Pharmaceuticals, Inc.
    Inventors: Alexey Alexandrovich LUGOVSKOY, Jason BAUM, Chrystal U. LOUIS
  • Publication number: 20140086888
    Abstract: The present invention concerns methods and compositions for treatment of locoregional nasopharyngeal carcinoma utilizing EBV-specific T cells. In specific embodiments, locoregional solid tumors are treated with cytotoxic T lymphocytes specific for at least one EBV antigen, such as LMP2, LMP1, and/or EBNA1, for example.
    Type: Application
    Filed: September 1, 2011
    Publication date: March 27, 2014
    Inventors: Helen E. Heslop, Karin Straathof, Stephen M.G. Gottschalk, Cliona M. Rooney, Chrystal U. Louis, Malcolm Brenner